Why Should You Put Adc Therapeutics SA (NYSE: ADCT) On Your Portfolio?
Redmile Group LLC recently announced the acquisition of new stake in Adc Therapeutics SA (NYSE:ADCT). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 14.18 million shares with purchase of 0.13 million shares. This fresh investment now brings its stake to 15.92% valued currently at $11.77 million. In addition, Millennium […]
Adc Therapeutics SA (NYSE: ADCT) – Suitable For Long Term Buy?
Redmile Group LLC recently announced the acquisition of new stake in Adc Therapeutics SA (NYSE:ADCT). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 14.18 million shares with purchase of 0.13 million shares. This fresh investment now brings its stake to 15.92% valued currently at $11.77 million. In addition, Millennium […]